Moreover, serum levels for CCL19 are greater in CLL patients than in age-matched healthy subjects and those. Related to CCR7 ligands, serum levels for CCL19 were comparable between CLL patients and age-matched healthy subjects (81). This evidence concerns the gene CCL19 and B-cell chronic lymphocytic leukemia.